NCBiotech News

Heat Biologics says it is doubling the size of its R&D facilities in Morrisville to some 15,000 square feet, to better support its drug development programs.

NCBiotech board member Michelle Berrey, M.D., has been appointed the president of research & development and chief medical officer at New-York-based biopharmaceutical innovator Intercept Pharmaceuticals.

Raleigh-based Veranex and global investment firm Summit Partners said they are joining forces to create a soup-to-nuts service provider for the medical technology industry.

The National Institutes of Health (NIH) awarded a $1.74 million research grant to study diabetic kidney disease to Elimelda Moige Ongeri, Ph.D., a professor and associate dean for research and innovation at North Carolina Agricultural and Technical State University.

If you're interested in learning about a career in North Carolina’s growing biomanufacturing sector, mark your calendar for Thursday, June 24, when Merck and BioNetwork will host a virtual career fair.

RTP's Biomason will develop biocement floor tiles with one of Europe’s largest fashion houses, H&M Group, for use in its retail stores.

The fast evolution of the COVID-19 outbreak into this global pandemic sparked an equally fast response from all quarters of North Carolina’s diverse life sciences community.

Verona Pharma, with U.S. headquarters in Raleigh, has clinched a $219 million deal to market its “first-in-class” drug, ensifentrine, targeting chronic obstructive pulmonary disease (COPD), in China.

With grant support from NCBiotech, engineers at Duke University have demonstrated a prototype X-ray scanning machine that reveals not just the shape of an object but its molecular composition.

Jonathan Maynard has traveled a long career path that will one day allow him to return to South Korea. And, it all started with JCC’s BioWork certificate program.

Biogen’s largest RTP facility at 5000 Davis Drive is producing the initial supplies of the company's Alzheimer’s treatment newly approved by the U.S. Food and Drug Administration.

The FDA has just granted Chimerix marketing approval for the tablet and oral suspension formulations of its smallpox treatment TEMBEXA (brincidofovir).

Bluebird bio, a gene therapy company with manufacturing facilities in Durham, is resuming clinical trials of potential therapies for two inherited blood disorders after clearance from the FDA.

North Carolina's attention-grabbing 15 life sciences company announcements so far in 2021, reflecting $2.9B+ in investment plans and 2,686 in new jobs, is on pace to surpass 2020's full-year bonanza of $3B+ in investments with plans to add 4,800+ jobs statewide.

GRAIL's new blood test that can detect more than 50 types of cancer in a single blood draw is now available in the United States with a prescription.